Skip to main content
Erschienen in: European Radiology 1/2014

01.01.2014 | Breast

The Impact of Bilateral Salpingo-Oophorectomy on Breast MRI Background Parenchymal Enhancement and Fibroglandular Tissue

verfasst von: E. R. Price, J. D. Brooks, E. J. Watson, S. B. Brennan, E. A. Comen, E. A. Morris

Erschienen in: European Radiology | Ausgabe 1/2014

Einloggen, um Zugang zu erhalten

Abstract

Objective

The objective of this study was to evaluate the effect of bilateral salpingo-oophorectomy (BSO) on background parenchymal enhancement (BPE) and the amount of fibroglandular tissue (FGT) seen on breast MRI.

Methods

Retrospective review identified 21 BRCA mutation carriers who underwent breast MRI before and after elective BSO. After exclusion of patients placed on postoperative hormone replacement therapy, there were 18 eligible patients. Blinded to surgical status, three independent readers used categorical scales to rate BPE (minimal, mild, moderate, marked) and the amount of FGT (fatty, scattered, heterogeneously dense, dense) on pre- and post-BSO MRI examinations. The sign test was used to assess for changes in the categorical ratings of BPE and FGT.

Results

Significant proportions of women demonstrated decreases in BPE and in the amount of FGT following oophorectomy (P = 0.004 and 0.02, respectively.) BPE decreases were larger and seen earlier than FGT changes. There was no significant relationship between age/body mass index and changes in BPE and FGT.

Conclusions

BPE and the amount of FGT seen on breast MRI are significantly decreased by oophorectomy; BPE decreases to a greater extent and earlier than FGT.

Key Points

Background parenchymal enhancement significantly decreases at breast MRI following oophorectomy.
Fibroglandular tissue significantly decreases on breast MRI following oophorectomy.
Decrease in background parenchymal enhancement is greater than in fibroglandular tissue.
Decrease in background parenchymal enhancement occurs earlier than in fibroglandular tissue.
Literatur
1.
Zurück zum Zitat Saslow D, Boetes C, Burke W et al (2007) American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 57:75–89PubMedCrossRef Saslow D, Boetes C, Burke W et al (2007) American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 57:75–89PubMedCrossRef
2.
Zurück zum Zitat Antoniou A, Pharoah PD, Narod S et al (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72:1117–1130PubMedCentralPubMedCrossRef Antoniou A, Pharoah PD, Narod S et al (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72:1117–1130PubMedCentralPubMedCrossRef
3.
Zurück zum Zitat Chen S, Parmigiani G (2007) Meta-analysis of BRCA1 and BRCA2 penetrance. J Clin Oncol : Off J Am Soc Clin Oncol 25:1329–1333CrossRef Chen S, Parmigiani G (2007) Meta-analysis of BRCA1 and BRCA2 penetrance. J Clin Oncol : Off J Am Soc Clin Oncol 25:1329–1333CrossRef
4.
Zurück zum Zitat Morris EA (2007) Diagnostic breast MR imaging: current status and future directions. Radiol Clin N Am 45:863–880, viiPubMedCrossRef Morris EA (2007) Diagnostic breast MR imaging: current status and future directions. Radiol Clin N Am 45:863–880, viiPubMedCrossRef
5.
Zurück zum Zitat Kuhl CK, Bieling HB, Gieseke J et al (1997) Healthy premenopausal breast parenchyma in dynamic contrast-enhanced MR imaging of the breast: normal contrast medium enhancement and cyclical-phase dependency. Radiology 203:137–144PubMed Kuhl CK, Bieling HB, Gieseke J et al (1997) Healthy premenopausal breast parenchyma in dynamic contrast-enhanced MR imaging of the breast: normal contrast medium enhancement and cyclical-phase dependency. Radiology 203:137–144PubMed
6.
Zurück zum Zitat Muller-Schimpfle M, Ohmenhauser K, Stoll P, Dietz K, Claussen CD (1997) Menstrual cycle and age: influence on parenchymal contrast medium enhancement in MR imaging of the breast. Radiology 203:145–149PubMed Muller-Schimpfle M, Ohmenhauser K, Stoll P, Dietz K, Claussen CD (1997) Menstrual cycle and age: influence on parenchymal contrast medium enhancement in MR imaging of the breast. Radiology 203:145–149PubMed
7.
Zurück zum Zitat Hussain Z, Roberts N, Whitehouse GH, Garcia-Finana M, Percy D (1999) Estimation of breast volume and its variation during the menstrual cycle using MRI and stereology. B J Radiol 72:236–245 Hussain Z, Roberts N, Whitehouse GH, Garcia-Finana M, Percy D (1999) Estimation of breast volume and its variation during the menstrual cycle using MRI and stereology. B J Radiol 72:236–245
8.
Zurück zum Zitat Graham SJ, Stanchev PL, Lloyd-Smith JO, Bronskill MJ, Plewes DB (1995) Changes in fibroglandular volume and water content of breast tissue during the menstrual cycle observed by MR imaging at 1.5 T. J Magn Reson Imaging : JMRI 5:695–701PubMedCrossRef Graham SJ, Stanchev PL, Lloyd-Smith JO, Bronskill MJ, Plewes DB (1995) Changes in fibroglandular volume and water content of breast tissue during the menstrual cycle observed by MR imaging at 1.5 T. J Magn Reson Imaging : JMRI 5:695–701PubMedCrossRef
9.
Zurück zum Zitat Delille JP, Slanetz PJ, Yeh ED, Kopans DB, Halpern EF, Garrido L (2005) Hormone replacement therapy in postmenopausal women: breast tissue perfusion determined with MR imaging—initial observations. Radiology 235:36–41PubMedCrossRef Delille JP, Slanetz PJ, Yeh ED, Kopans DB, Halpern EF, Garrido L (2005) Hormone replacement therapy in postmenopausal women: breast tissue perfusion determined with MR imaging—initial observations. Radiology 235:36–41PubMedCrossRef
10.
Zurück zum Zitat Harvey JA, Santen RJ, Petroni GR et al (2008) Histologic changes in the breast with menopausal hormone therapy use: correlation with breast density, estrogen receptor, progesterone receptor, and proliferation indices. Menopause 15:67–73PubMed Harvey JA, Santen RJ, Petroni GR et al (2008) Histologic changes in the breast with menopausal hormone therapy use: correlation with breast density, estrogen receptor, progesterone receptor, and proliferation indices. Menopause 15:67–73PubMed
11.
Zurück zum Zitat Pfleiderer SO, Sachse S, Sauner D et al (2004) Changes in magnetic resonance mammography due to hormone replacement therapy. Breast Cancer Res : BCR 6:R232–R238PubMedCentralPubMedCrossRef Pfleiderer SO, Sachse S, Sauner D et al (2004) Changes in magnetic resonance mammography due to hormone replacement therapy. Breast Cancer Res : BCR 6:R232–R238PubMedCentralPubMedCrossRef
12.
Zurück zum Zitat King V, Gu Y, Kaplan JB, Brooks JD, Pike MC, Morris EA (2012) Impact of menopausal status on background parenchymal enhancement and fibroglandular tissue on breast MRI. Eur Radiol 22:2641–2647PubMedCrossRef King V, Gu Y, Kaplan JB, Brooks JD, Pike MC, Morris EA (2012) Impact of menopausal status on background parenchymal enhancement and fibroglandular tissue on breast MRI. Eur Radiol 22:2641–2647PubMedCrossRef
13.
Zurück zum Zitat King V, Kaplan J, Pike MC et al (2012) Impact of tamoxifen on amount of fibroglandular tissue, background parenchymal enhancement, and cysts on breast magnetic resonance imaging. Breast J 18:527–534PubMedCrossRef King V, Kaplan J, Pike MC et al (2012) Impact of tamoxifen on amount of fibroglandular tissue, background parenchymal enhancement, and cysts on breast magnetic resonance imaging. Breast J 18:527–534PubMedCrossRef
14.
Zurück zum Zitat Eng-Wong J, Orzano-Birgani J, Chow CK et al (2008) Effect of raloxifene on mammographic density and breast magnetic resonance imaging in premenopausal women at increased risk for breast cancer. Cancer Epidemiol Biomark Prev : Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol 17:1696–1701CrossRef Eng-Wong J, Orzano-Birgani J, Chow CK et al (2008) Effect of raloxifene on mammographic density and breast magnetic resonance imaging in premenopausal women at increased risk for breast cancer. Cancer Epidemiol Biomark Prev : Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol 17:1696–1701CrossRef
15.
Zurück zum Zitat King V, Goldfarb SB, Brooks JD et al (2012) Effect of aromatase inhibitors on background parenchymal enhancement and amount of fibroglandular tissue at breast MR imaging. Radiology 264:670–678PubMedCrossRef King V, Goldfarb SB, Brooks JD et al (2012) Effect of aromatase inhibitors on background parenchymal enhancement and amount of fibroglandular tissue at breast MR imaging. Radiology 264:670–678PubMedCrossRef
16.
Zurück zum Zitat King V, Brooks JD, Bernstein JL, Reiner AS, Pike MC, Morris EA (2011) Background parenchymal enhancement at breast MR imaging and breast cancer risk. Radiology 260:50–60PubMedCrossRef King V, Brooks JD, Bernstein JL, Reiner AS, Pike MC, Morris EA (2011) Background parenchymal enhancement at breast MR imaging and breast cancer risk. Radiology 260:50–60PubMedCrossRef
17.
Zurück zum Zitat D'Orsi CJ, Mendelson EB, Ikeda DM et al (2003) Breast Imaging Reporting and Data System: ACR BI-RADS—Breast Imaging Atlas. American College of Radiology, Reston, VA D'Orsi CJ, Mendelson EB, Ikeda DM et al (2003) Breast Imaging Reporting and Data System: ACR BI-RADS—Breast Imaging Atlas. American College of Radiology, Reston, VA
18.
Zurück zum Zitat Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33:159–174PubMedCrossRef Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33:159–174PubMedCrossRef
19.
Zurück zum Zitat Rebbeck TR, Kauff ND, Domchek SM (2009) Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers. J Natl Cancer Inst 101:80–87PubMedCentralPubMedCrossRef Rebbeck TR, Kauff ND, Domchek SM (2009) Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers. J Natl Cancer Inst 101:80–87PubMedCentralPubMedCrossRef
20.
Zurück zum Zitat Fakkert IE, Mourits MJ, Jansen L et al (2012) Breast cancer incidence after risk-reducing salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers. Cancer Prev Res (Phila) 5:1291–1297CrossRef Fakkert IE, Mourits MJ, Jansen L et al (2012) Breast cancer incidence after risk-reducing salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers. Cancer Prev Res (Phila) 5:1291–1297CrossRef
21.
Zurück zum Zitat Berliner JL, Fay AM (2007) Risk assessment and genetic counseling for hereditary breast and ovarian cancer: recommendations of the National Society of Genetic Counselors. J Genet Couns 16:241–260PubMedCrossRef Berliner JL, Fay AM (2007) Risk assessment and genetic counseling for hereditary breast and ovarian cancer: recommendations of the National Society of Genetic Counselors. J Genet Couns 16:241–260PubMedCrossRef
22.
Zurück zum Zitat Ciatto S, Houssami N, Apruzzese A et al (2005) Categorizing breast mammographic density: intra- and interobserver reproducibility of BI-RADS density categories. Breast 14:269–275PubMedCrossRef Ciatto S, Houssami N, Apruzzese A et al (2005) Categorizing breast mammographic density: intra- and interobserver reproducibility of BI-RADS density categories. Breast 14:269–275PubMedCrossRef
Metadaten
Titel
The Impact of Bilateral Salpingo-Oophorectomy on Breast MRI Background Parenchymal Enhancement and Fibroglandular Tissue
verfasst von
E. R. Price
J. D. Brooks
E. J. Watson
S. B. Brennan
E. A. Comen
E. A. Morris
Publikationsdatum
01.01.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
European Radiology / Ausgabe 1/2014
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-013-2993-9

Weitere Artikel der Ausgabe 1/2014

European Radiology 1/2014 Zur Ausgabe

Endlich: Zi zeigt, mit welchen PVS Praxen zufrieden sind

IT für Ärzte Nachrichten

Darauf haben viele Praxen gewartet: Das Zi hat eine Liste von Praxisverwaltungssystemen veröffentlicht, die von Nutzern positiv bewertet werden. Eine gute Grundlage für wechselwillige Ärzte und Psychotherapeuten.

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

S3-Leitlinie zu Pankreaskrebs aktualisiert

23.04.2024 Pankreaskarzinom Nachrichten

Die Empfehlungen zur Therapie des Pankreaskarzinoms wurden um zwei Off-Label-Anwendungen erweitert. Und auch im Bereich der Früherkennung gibt es Aktualisierungen.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.